5 Einträge gefunden

1. Melanoma antigen family A identified by the bimodality index defines a subset of triple negative breast cancers as candidates for immune response augmentation.

   1. Karn, Thomas
   2. Pusztai, Lajos
   3. Ruckhäberle, Eugen
   4. Liedtke, Cornelia
   5. Müller, Volkmar
   6. Schmidt, Marcus
   7. Metzler, Dirk

   2012 - Forschungsinformationssystem des UKE
2. A clinically relevant gene signature in triple negative and basal-like breast cancer.

   1. Rody, Achim
   2. Karn, Thomas
   3. Liedtke, Cornelia
   4. Pusztai, Lajos
   5. Ruckhaeberle, Eugen
   6. Hanker, Lars
   7. Gaetje, Regine

   2011 - Forschungsinformationssystem des UKE - frei zugänglich
3. Gene expression profiling of luminal B breast cancers reveals NHERF1 as a new marker of endocrine resistance.

   1. Karn, Thomas
   2. Ruckhäberle, Eugen
   3. Hanker, Lars
   4. Müller, Volkmar
   5. Schmidt, Marcus
   6. Solbach, Christine
   7. Gätje, Regine

   2011 - Forschungsinformationssystem des UKE
4. Homogeneous datasets of triple negative breast cancers enable the identification of novel prognostic and predictive signatures.

   1. Karn, Thomas
   2. Pusztai, Lajos
   3. Holtrich, Uwe
   4. Iwamoto, Takayuki
   5. Shiang, Christine Y
   6. Schmidt, Marcus
   7. Müller, Volkmar

   2011 - Forschungsinformationssystem des UKE - frei zugänglich
5. Loss of Plexin B1 is highly prognostic in low proliferating ER positive breast cancers--results of a large scale microarray analysis.

   1. Rody, Achim
   2. Karn, Thomas
   3. Ruckhäberle, Eugen
   4. Hanker, Lars
   5. Metzler, Dirk
   6. Müller, Volkmar
   7. Solbach, Christine

   2009 - Forschungsinformationssystem des UKE